A股異動 | ST海馬(000572.SZ)一字漲停 與北京航天試驗技術研究所戰略合作 發展氫能產業
格隆匯4月12日丨ST海馬(000572.SZ)一字漲停,報3.3元,買一封單近12萬手,最新總市值54億元。ST海馬昨晚公吿稱,公司與北京航天試驗技術研究所簽署戰略合作協議。根據協議,雙方擬合作共建海南科研用水電解制氫設施和撬裝式加氫站;擬合作共建海南環島固定式加氫站羣,促進氫能汽車示範推廣;擬共同開展低温液氫開發與應用技術研究,推動車載液氫使用;擬共同研究運用“綠氫”技術,幫助海南省實現“氫能社會”願景;雙方擬共享氫能行業最新發展情報,參與氫能相關標準建設等。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.